Ignite Creation Date:
2025-12-24 @ 1:50 PM
Ignite Modification Date:
2026-02-08 @ 3:11 AM
Study NCT ID:
NCT00992095
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2009-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions
Sponsor:
Roxane Laboratories
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BUPR-T8-PVFS-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Elizabeth Ernst, Director - Drug Regulatory Affairs and Medical Affairs
Old Organization:
Roxane Laboratories, Inc.